Correlation Between XOMA and Protagenic Therapeutics

Can any of the company-specific risk be diversified away by investing in both XOMA and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XOMA and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between XOMA Corporation and Protagenic Therapeutics, you can compare the effects of market volatilities on XOMA and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XOMA with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of XOMA and Protagenic Therapeutics.

Diversification Opportunities for XOMA and Protagenic Therapeutics

-0.78

Correlation Coefficient

XOMA  Protagenic Therapeutics

Pay attention - limited upside

The 3 months correlation between XOMA and Protagenic is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding XOMA Corp. and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and XOMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XOMA Corporation are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of XOMA i.e., XOMA and Protagenic Therapeutics go up and down completely randomly.

Pair Corralation between XOMA and Protagenic Therapeutics

Assuming the 90 days horizon XOMA Corporation is expected to generate 0.12 times more return on investment than Protagenic Therapeutics. However, XOMA Corporation is 8.19 times less risky than Protagenic Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Protagenic Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  2,041  in XOMA Corporation on December 2, 2024 and sell it today you would earn a total of  493.00  from holding XOMA Corporation or generate 24.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	99.8%
Values	Daily Returns

XOMA Corp.  vs.  Protagenic Therapeutics

XOMA

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in XOMA Corporation are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, XOMA is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Protagenic Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Protagenic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with XOMA and Protagenic Therapeutics

The main advantage of trading using opposite XOMA and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XOMA position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.

The idea behind XOMA Corporation and Protagenic Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.